Medicine

Niacin, meals intake as well as cardiovascular impacts

.Nature Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meals...

Opportunities and difficulties for patient-reported result analysis in multimorbidity analysis and also technique

.Contending passions.S.E.H. gets backing coming from the National Principle of Health as well as Tre...

Hibernation scientific research harnessed to handle being overweight and customize metabolic rate

.Attribute Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy comprehend...

CAR- T and also mobile gene treatments are actually also expensive

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manu...

The WHO genomics plan of benefit equitable application of human genomics for global wellness

.The publication of the initial draft of the human genome series in 20011 was observed by the advanc...

A time-stratified, case\u00e2 $ \"crossover study of heat visibility as well as perinatal death coming from 16 medical centers in sub-Saharan Africa

.Amongst 138,015 hospital-based singleton births in four sub-Saharan African nations, our company no...

Advancing global antibiotic research study, progression as well as accessibility #.\n\nMurray, C. J. L. et al. International trouble of microbial antimicrobial protection in 2019: a step-by-step evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of certain commitments as well as action in the feedback to antimicrobial protection. International Leaders Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Health And Wellness Association. That posts list of germs for which brand new antibiotics are urgently required. Planet Health Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Wellness Organization. WHO bacterial concern virus list, 2024: microbial virus of public health usefulness to assist study, progression as well as approaches to prevent and also control antimicrobial protection. World Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative access. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Health Association. 2023 antibacterial brokers in clinical and also preclinical development: an overview and also analysis. Planet Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Testimonial. May 19, 2016 \u00e2 $\" Tackling drug-resistant infections internationally: last file as well as suggestions. Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: files and rundown. Steer AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: a call for concurrent action on anti-biotics research and development. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Brief 51: Exactly how can the EU help lasting innovation and also access to effective antibiotics? policy alternatives for existing and new medicines. European Observatory on Wellness Units and also Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Prescription antibiotic usage and also resistance\u00e2 $\" verifying the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Association. 2021 Knowledgeable classification. WHO accessibility, check out, get, classification of prescription antibiotics for analysis and also surveillance of utilization. Planet Wellness Company https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Centre for Disease Deterrence as well as Control. Antimicrobial resistance aim ats: how can we reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Organization. Absence of technology readied to undermine antibiotic performance and also wellness increases. Globe Health Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial protection is actually linked to environment change: an overview of pair of entwined global challenges. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial diseases: we need to have important activity as well as financial investment that focus on the weakest web link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health Association. Immunization protection. World Health Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection deterrence and management in low-resource setups: the requirement for the nearby, the contextual and the pragmatic. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of applying antimicrobial stewardship tools in reduced to middle income countries (LMICs). Corrupt. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A quick background of the antibiotic time: trainings knew and difficulties for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Individual gain access to in 14 high-income countries to brand new antibacterials authorized by the US Food and Drug Administration, European Medicines Organization, Japanese Pharmaceuticals and also Medical Equipment Agency, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Wellness Association. 2021 anti-bacterial agents in medical and preclinical advancement: a summary and also study. Planet Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the business economics should support the scientific research. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of technology in antibacterial therapies. Medical Advancement Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Examining medical professional utilization of next-generation anti-biotics versus immune Gram-negative diseases in united state medical facilities: a retrospective cohort study. Ann. Intern. Medication. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in antibacterial therapies. Medical Advancement Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A step-by-step testimonial and also important examination of motivation tactics for discovery and progression of novel anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nWellness Unexpected Emergency Readiness and also Feedback Authorization. Trial and error of clinical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Compensation. Pre-draft proposal for an European partnership under Perspective Europe One Health And Wellness Antimicrobial Protection. International Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Prescription Antibiotic Experimentation Partnership. Entasis Therapies as well as the Global Prescription Antibiotic Research &amp Growth Alliance to cultivate a new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of business- as well as non-industry-sponsored medical trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health And Wellness Institution. Number of clinical test registrations through place, condition, period of growth, age and also sexual activity of trial participants (1999\u00e2 $ \"2022). Planet Health Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Antibiotic Research and Development Partnership. NeoSept1: a research study to find out the position of existing and also brand-new antibiotics combos to deal with newborns who are in medical center along with intense sepsis. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Organization of Canada. Federal government of Canada brings in necessary expenditure to combat antimicrobial resistance (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Prescription Antibiotic Experimentation Alliance. Asia authorities funding assists GARDP\u00e2 $ s initiatives to respond to antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Groundwork. Novo Nordisk Base companions along with CARB-X to combat drug-resistant contaminations. novo nordisk structure https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Wellness and also Digital Manager Agency. Research on taking AMR health care countermeasures to the marketplace. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Predicting the suitable size of international pull motivations for antibacterial medicines. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entrance perks for the growth of new antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Industry motivations as well as antibiotic protection: an intro to the antibiotic sensitivity bonus offer. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG accelerated commitment for subscription-based buying of unique antimicrobials as well as its own anticipated roi. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in brand new antibiotics would pay \u00e2 $\" for every person. Office of Wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up fight against lethal diseases complying with productive world-first captain. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Congress. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Percentage. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Reimbursement models to attack market failings for antimicrobials: approaches consumed France, Germany, Sweden, the UK, and the USA. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers and Associations. Coming from protection to resilience: what could the future antibiotic pipe appear like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Worldwide AMR R&ampD Center &amp Planet Health Company. Incentivising the growth of brand-new anti-bacterial therapies: 2023 progress report by the Global AMR R&ampD Center as well as That. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration version for anti-biotics looked at prosperous? Lancet Germ 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the advancement and also keeping the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, regional, and nationwide root causes of child death in 2000\u00e2 $ \"13, along with estimates to notify post-2015 top priorities: an upgraded organized review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medicine scarcities coming from 2001 to 2013: ramifications for medical exercise. Clin. Affect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French reporting unit for drug lacks: summary and also styles coming from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Analysis of WHO antibiotic consumption and also accessibility targets in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Battling the phonies: taking on low quality and also falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring much easier to secure antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Society for Laboratory Medication. Plan brief and also infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for individual make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: analysis of core warehouses materials to in-patient treatment health and wellness locations from 2017 to 2019 in Uganda. Trop. Medication. Affect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Varieties in the consumption of antimicrobial medicines in the European region, 2014\u00e2 $ \"2018: searchings for and ramifications coming from ESAC-Net as well as WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medication lack: triggers, effect, and reduction techniques. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Person access in 14 high-income countries to brand-new antibacterials authorized by the US Food and Drug Administration, European Medicines Organization, Japanese Pharmaceuticals and also Medical Gadget Agency, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Wasted antibiotics: a follow-up supply research study in Europe, the USA, Canada as well as Australia. Int. J. Antimicrob. Representatives 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness development for worldwide health. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Business Collaboration. The 2023 AMR Sector Collaboration progress poll: production as well as the setting. amr Market Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can health care products be cultivated on a charitable manner? Exploring product development relationships for ignored conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the global social rate of interest. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Control and also Deterrence. Africa CDC spearheads bold relocate to secure Africa\u00e2 $ s health future by developing a 50 billion buck clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health intellectual property licensing contracts to increase accessibility to wellness technologies: an insider\u00e2 $ s account. BMJ Glob. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service models for trial and error along with price needs are actually required to attain reasonable pricing of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Gas. Conservation and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Prescription Antibiotic R &amp D Partnership. Shinogi, GARDP and CHAI declare landmark license and also partnership contracts to deal with bacterial diseases next to expanding access to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Alliance. Leaving behind the lab: tracking the downtrend in AMR R&ampD experts. amr Market Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to activity on antimicrobial resistance. G7G20 Papers Database https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Coalition on Growing Old &amp Infectious Health Conditions Culture of America. 2024 AMR readiness mark report card. Evaluating federal government action on AMR policy. Global Coalition on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items as well as Horticulture Association of the United Nations, United Nations Atmosphere Program, Globe Health And Wellness Company &amp. Planet Company for Pet Health And Wellness. Global data source for tracking antimicrobial protection (AMR): country self-assessment poll (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the globa...

Integrating liver endpoints in medical tests of heart and also renal condition

.Attribute Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpo...

FALSE:: INACCURACY: UNSUPPORTED ENCODING...

Artificial knowledge led screening process for cardiomyopathies in an obstetric populace: a practical randomized clinical test

.Trial concept as well as oversightThe Testing for PEripartum Cardiomyopathies with Artificial Intel...